There are those times that one is curious to get answers to some boggling medical issues and do not want to pay their doctors a visit. Well, searching the internet for these answers may not guarantee you the best answer you need, leave alone being bombarded with many loads of unauthentic answers.There is only one platform that can guarantee you the most sort after answers, Oncotarget. This peer to review open access medical journal is not only loved by readers for its fame but also for its research that covers all aspects of oncology. This journal specializes on Microbiology, Neurotarget, Neuroscience, Pathology, Immunology, Circadian Rhythm, aging, Autophagy not forgetting Cell Death; Oncology was established back in 2010, and it up to date it has up to 50 employees.
Since the inception of this journal, it has continually emphasized research on cancer, the potential targets for therapy, as well as treatment protocols that should be applied to manage the treatment of cancer patient’s best. Apart from this, the journal focusses on the influence of management programs, as well as the therapeutic agents and protocols, such as patient’s quality of life and adherence.No stone is left unturned, as the journal explores evidence behind all therapies, both new and existing, to improve the outcomes. The exploration process does not stop there as it goes on to demonstrate the treatments administration.
At the helm of the journal’s editorial docket, there is Andrei V. Gudcov, who is the editor in chief. He acquired an experimental oncology and molecular biology degree from the National Cancer Center and Moscow State University. In Cleveland BioLabs, Inc. he is the co-founder. He is also the Chief Scientific Officer at the Tartis, Inc. In his career, Mr. Andrei specializes in drug discovery, gene discovery, and molecular targets for cancer treatment.Mikhail V. Blagosklonny also assists Mr. Andrei from the Roswell Park Cancer Institute, Buffalo, NY where he was a professor. Mr. Milkhail specialized in cancer and aging studies. He went to First Pavlov State Medical University of St. Peterburg where he got his M.D. in internal medicine and also Ph.D. in experimental medicine and cardiology.